Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design

BACKGROUND: Heart failure (HF) and diabetes (DM) are a lethal combination. The current armamentarium of anti-diabetic agents has been shown to be less efficacious and sometimes even harmful in diabetic patients with concomitant cardiovascular disease, especially HF. Sodium glucose linked co-transpor...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Jagdeep S. S., Fathi, Amir, Vickneson, Keeran, Mordi, Ify, Mohan, Mohapradeep, Houston, J. Graeme, Pearson, Ewan R., Struthers, Allan D., Lang, Chim C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946228/
https://www.ncbi.nlm.nih.gov/pubmed/27422625
http://dx.doi.org/10.1186/s12933-016-0419-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946228/
https://www.ncbi.nlm.nih.gov/pubmed/27422625
http://dx.doi.org/10.1186/s12933-016-0419-0

Ejemplares similares